50
Participants
Start Date
January 3, 2022
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2027
Imatinib tablets
Imatinib interruption
NOT_YET_RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
CHU Besançon, Besançon
NOT_YET_RECRUITING
Institut Claudius Regaud, Toulouse
RECRUITING
Institut Bergonié, Bordeaux
NOT_YET_RECRUITING
Centre Eugène Marquis, Rennes
NOT_YET_RECRUITING
Institut de Cancérologie Lucien NEUWIRTH, Saint-Paul-en-Jarez
NOT_YET_RECRUITING
Institut de Cancérologie de l'Ouest - Site Réné Gauducheau, Saint-Herblain
RECRUITING
CHU de Reims, Reims
NOT_YET_RECRUITING
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
RECRUITING
Centre Léon Bérard, Lyon
NOT_YET_RECRUITING
Institut Curie, Paris
RECRUITING
CHU Dupuytren, Limoges
RECRUITING
Institut Goustave Roussy, Villejuif
Centre Leon Berard
OTHER